Ceramide Containing Multivesicular Emulsion Application . . .

National Institutes of Health (NIH)

Status: Completed

Conditions: Foot Dryness in Patients With NIDDM; Foot Transepidermal Water Loss in Patients in NIDDM

Treatments: Drug: CeraVe

Study type: Interventional

Funder types: NIH

Identifiers

NCT00947726

DK7676 (completed)

Details and patient eligibility

About

We believe that using a ceramide based foot cream two times a day for two weeks will prevent water loss and overall foot dryness in patients with non-insulin dependent diabetes.

Enrollment: 30 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• >18 years of age
• non insulin-dependent diabetes
• moderate to severe xerosis of both feet [a score of at least 4 on a scale of 0 (normal) to 8 (deep fissuring)]
• capable of understanding and signing consent form

Exclusion criteria

• history of ichthyosis vulgaris
• known hypersensitivity to the topical product used in the study
• previous use of high potency steroids (class I and II) in past 2 week
• presence of acute skin disease or infection, such as vasculitis or cellulitis
• presence of foot ulcer
• evidence of gangrene

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)